AlphaYouGS
Insider buying
Gary S. Stetz bought $50K of Hepion Pharmaceuticals, Inc. (HEPA) stock
Gary S. Stetz, Interim CEO of Hepion Pharmaceuticals, Inc. (HEPA), bought 1,250,000 shares of HEPA stock worth $50K, per an SEC Form 4 filed Apr 27, 2026.
It was an open-market purchase.
The trade happened on Apr 21, 2026, 6 days before it was made public.
- Traded
- Apr 21, 2026
- Disclosed
- Apr 27, 2026
- Filing delay
- 6 days
- Role
- Interim CEO
- Source
- SEC Form 4
More HEPA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.